Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Another snap shot of VRX vs CXR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Lumberfeverlongon Nov 25, 2016 9:33pm
168 Views
Post# 25516152

RE:Another snap shot of VRX vs CXR

RE:Another snap shot of VRX vs CXR[the company had $492M at the end of Q3. Don't know what reputable source you are getting your information from. quote=BinTraden]
CXR   VRX  
Cash & Short-Term Investment 213.72 M Cash & Short-Term Investment 659.50 M
Total Debt 4.26 B Total Debt 30.45 B
Total Liabilities 5.16 B Total Liabilities 41.49 B
Total Shareholder's Equity 395.65 M Total Shareholder's Equity 4.17 B
Book Value Per Share 7.76 Book Value Per Share 11.99

[/quote]

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities